MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism dementia complex(PDC)"

  • 2018 International Congress

    Brain Mechanisms of Associative Memory Deficits in Parkinson’s Disease without Dementia

    T. Alrazi, J. Cheetham, L. Derwent, A. Hanganu, T. Hammer, I. Kathol, M. Kibreab, S. Lang, N. Ouellet, J. Provost, M. Ramezani, J. Sarna, E. Yoon, O. Monchi (Calgary, AB, Canada)

    Objective: Characterization of neural mechanisms of associative memory deficits in Parkinson’s disease (PD) without dementia (PD-non-Dementia). Background: The early presence of memory deficits in PD…
  • 2018 International Congress

    Abnormal NMDA-related Electrophysiology in Parkinson Disease Dementia

    J.C. Chen, H.M. Heng, C.H. Tsai (Taichung, Taiwan)

    Objective: Investigate mismatch negativity in Parkinson disease with dementia. Background: Parkinson’s disease with dementia (PDD) is an important cause of cognitive impairment in Parkinson’s disease…
  • 2018 International Congress

    Hypometabolism of the posterior parietal cortex in PD with dementia: [18F]FDG PET study

    N.R. Choi, K.W. Park, M.S. Kim, J.H. Ko, S.J. Kim, S.J. Chung, C.S. Lee (Seoul, Republic of Korea)

    Objective: To investigate the neuroimaging marker for dementia in Parkinson’s disease (PD) patients using [18F]FDG PET. Background: Dementia may occur in patients with PD during…
  • 2018 International Congress

    Novel mechanistic involved in targeting Parkinsons Disease by Indolocarbazole derivatives as inhibitors against Cyclin Dependent kinases using molecular modelling and simulation approaches

    S. Iqbal (Chennai, India)

    Objective: To validate effect of Indolocarbazole derivatives on Cyclin dependent kinase for treating Parkinson's (Preliminary work in context of CDK5 assay and Simulations have been…
  • 2017 International Congress

    Extended “Timed Up and Go”: A Clinical Indicator of Cognitive State in Parkinson’s Disease?

    T. Evans, A. Jefferson, M. Byrnes, S. Walters, S. Ghosh, F. Mastaglia, B. Power, R. Anderton (Perth, Australia)

    Objective: To evaluate an extended Timed Up and Go (extended-TUG) as a potential holistic indicator of Parkinson’s disease; hypothesised to correlate closely with disease severity…
  • 2017 International Congress

    PET-MRI Imaging in Parkinson Dementia Complex of Guam: A Case Report

    A. Tran, K. Chan, V. Kharidi, E. Goldstein, R. Burns, P. Reyes (Phoenix, AZ, USA)

    Objective: To describe the PET-MRI brain and DaTscan findings in a case of Parkinson Dementia Complex of Guam. Background: The indigenous Chamorro people of Guam…
  • 2017 International Congress

    GBA mRNA is diminished in brain and blood of Lewy body diseases

    K. Beyer, J. Campdelacreu, L. Ispierto, D. Vilas, R. Reñé, R. Alvarez (Badalona, Spain)

    Objective: To find out whether GBA deficiency starts at the transcriptional level and if it also involves alternative splicing. To study GBA expression changes in…
  • 2017 International Congress

    Difficulties in executing the MDS recommendations in the brazilian population

    E. Carreira, E. CARREIRA, A. PRADO, N. BRAZ, F. TAVARES, N. ROCHA, L. DE SOUZA, F. CARDOSO, A. TEIXEIRA (Belo Horizonte, Brazil)

    Objective: To investigate the usefulness of the trail making test (TMT)-A and TMT-B in the cognitive evaluation of a Brazilian sample of patients with PD.…
  • 2017 International Congress

    Differential peculiarities of cognitive disorders in Parkinson’s disease dementia and Vascular dementia

    V. Mykhaylov, I. Zdesenko (Kharkiv, Ukraine)

    Objective:  To study differential peculiarities of cognitive functions disorders in Parkinson's disease (PD) dementia and vascular dementia (VD). Background: 44 VD and 18 PD dementia…
  • 2017 International Congress

    Sleep architecture in Parkinson´s disease and Parkinson’s disease associated dementia

    L. Sousa, I. Laranjinha, J. Lopes, J. Ramalheira, A.M. da Silva, A.B. Lima, M. Magalhães (Porto, Portugal)

    Objective: To evaluate the differences in early sleep architecture between patients with Parkinson’s disease (PD) and Parkinson’s disease associated dementia (PDD). Background: Disorders of sleep…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley